Immune responses to EBNA1: biomarkers in MS?
Lünemann
Jan D
JD
Ascherio
Alberto
A
D001402:B-Lymphocytes / Q000276:immunology; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D015984:Causality; D018450:Disease Progression; D019309:Epstein-Barr Virus Nuclear Antigens / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D007107:Immune System / Q000503:physiopathology; D007074:Immunoglobulin G / Q000032:analysis / Q000097:blood; D007244:Infectious Mononucleosis / Q000150:complications* / Q000276:immunology* / Q000503:physiopathology; D018716:Molecular Mimicry / Q000276:immunology; D009103:Multiple Sclerosis / Q000276:immunology* / Q000503:physiopathology / Q000821:virology*; D010641:Phenotype; D013601:T-Lymphocytes / Q000276:immunology; D015854:Up-Regulation / Q000276:immunology
D015415:Biomarkers; D019309:Epstein-Barr Virus Nuclear Antigens; D007074:Immunoglobulin G; C417029:EBV-encoded nuclear antigen 1